Prospective scientific and technological analysis about cancer related to the head and neck region
DOI:
https://doi.org/10.33448/rsd-v12i13.44127Keywords:
Head and neck neoplasms; Immunotherapy; Vaccine.Abstract
They are also known as head and neck squamous cell carcinoma and are a biologically diverse and genetically heterogeneous disease. Due to the advanced condition, surgical resection of the tumor and lymph node drainage are widely used, especially with subsequent radiation associated or not with chemotherapy. Because the treatment is based primarily on surgery, followed by radio or chemotherapy, the patient's quality of life is impacted and ends up influencing the improvement of the condition in general. The present study aimed to carry out a mapping of Technological and Scientific Prospecting in a systematic qualitative and quantitative way in search of scientific articles and patents regarding cancers related to the head and neck region and their developed immunotherapies. Science Direct and PubMed were used as databases for scientific prospecting and, for technological prospecting, the Google Patents database was used. Publications were limited between the years 2012-2022 and documents made available in full were selected, in order to cover as many articles as possible directed to the objective of the study based on a refinement using the descriptors “head and neck cancer; immunotherapies; therapeutic vaccines”. It can be seen that immunotherapy is a path to this type of sought-after alternative. It was possible to observe that there is a need for studies in this area due to its importance for people's quality of life.
References
Argenziano, G., Briatico, G., Brancaccio, G., Alfano, R., Moscarella, E., & Lallas, A. (2021). Pistas clínicas para evitar a falta de melanoma quando a morfologia não é suficiente. Conceito de prática de Dermatol. 11(4), e 2021143. DOI: https://doi.org/10.5826/dpc.1104143.
Chevallier, P., Saiagh, S., Dehame, V., Guillaume, T., Peterlin, P., Bercegeay, S., le Bris, Y., Bossard, C., Gauvrit, I., Dreno, B., Juge-Morineau, N., Béné, M. C., & Gregoire, M. (2021). A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients. Human Vaccines & Immunotherapeutics. 17(10), 3511–3514. https://doi.org/10.1080/21645515.2021.1943991.
Chow, J. C., Ngan, R. K., Cheung, K. M., & Cho, W. C. (2019). Abordagens imunoterapêuticas no carcinoma de nasofaringe. Opinião de especialistas em terapia biológica. 19 (11), 1165-1172. https://doi.org/10.1080/14712598.2019.1650910.
Chueke, G. V., & Amatucci, M. (2015). O que é bibliometria? Uma introdução ao Fórum. InternexT - Revista Eletrônica de Negócios Internacionais da ESPM. 10(2), 1-5.
Cramer, J. D., Burtness, B., & Ferris, R. L. (2019). Immunotherapy for head and neck cancer: Recent advances and future directions. Oral oncology. 99, 104460. https://doi.org/10.1016/j.oraloncology.2019.104460.
Del Giudice, F., Busetto, G. M., Gross, M. S., Maggi, M., Sciarra, A., Salciccia, S., Ferro, M., Sperduti, I., Flammia, S., Canale, V., Chung, B. I., Conti, S. L., Eisenberg, M. L., Skinner, E. C., & de Berardinis, E. (2021). Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis. Journal of Cancer Research and Clinical Oncology. 147(10), 3073–3080. https://doi.org/10.1007/S00432-021-03571-0/FIGURES/2.
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International journal of cancer. 144(8), 1941–1953. https://doi.org/10.1002/ijc.31937.
Feng, R. M., Zong, Y. N., Cao, S. M. & Xu, R. H. (2019). Situação atual do câncer na China: boas ou más notícias das Estatísticas Globais do Câncer de 2018? Comunicações sobre câncer, 39 (1), 1-12. https://doi.org/10.1186/s40880-019-0368-6
Firnhaber, C., Swarts, A., Jezile, V., Mulongo, M., Goeieman, B., Williams, S., Faesen, M., Michelow, P., & Wilkin, T. (2021). Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial. Clinical Infectious Diseases. 73(7), e2211–e2216. https://doi.org/10.1093/CID/CIAA1456.
Gupta, V., Levy, J., Allen-Ayodabo, C., Amirazodi, E., Davis, L., Li, Q., Mahar, A., Coburn, N. G & PRESTO Study Investigators. (2020). Registro Populacional de Tumores Esofágicos e Estômagos em Ontário (PRESTO): protocolo para um banco de dados clínico e patológico multicêntrico, incluindo 25.000 pacientes. BMJ aberto. 10 (5), e032729. https://doi.org/10.1136/bmjopen-2019-032729.
Granier, C., Karaki, S., Roussel, H., et al. (2016). [Imunoterapia do câncer: descobertas racionais e recentes]. La Revue de Medicine Interne. Out; 37(10), 694-700. 10.1016/j.revmed.2016.05.023.
Grønhøj, C., Jensen, D. H., Dehlendorff, C., et al. (2018). Desenvolvimento e validação externa de nomogramas em pacientes com câncer de orofaringe com status de HPV-DNA conhecido: um estudo multicêntrico europeu (OroGrams). Br J Câncer. 118, 1672-1681. https://doi.org/10.1038/s41416-018-0107-9.
Hayes, C. (2021). Cellular immunotherapies for cancer. Irish journal of medical science. 190(1), 41–57. https://doi.org/10.1007/s11845-020-02264-w.
Hiraoka, A., Kumada, T., Atsukawa, M., et al. (2019). Fator prognóstico de lenvatinib para carcinoma hepatocelular irressecável em condições do mundo real - análise multicêntrica. Câncer Med. 8, 3719 – 3728. https://doi.org/10.1002/cam4.2241.
Hong, M., Tang, K., Qian, J., Deng, H., Zeng, M., Zheng, S., Ding, K., Du, Y., & Sun, R. (2018). Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma. Critical reviews in oncogenesis. 23(3-4), 219–234. https://doi.org/10.1615/CritRevOncog.2018027528.
Lee, A., Tan, L., & Lim, C. M. (2018). Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer. Oral oncology. 84, 61–70. https://doi.org/10.1016/j.oraloncology.2018.07.011.
Leemans, C. R., Snijders, P., & Brakenhoff, R. H. (2018). The molecular landscape of head and neck cancer. Nature reviews. Cancer, 18(5), 269–282. https://doi.org/10.1038/nrc.2018.11.
Letourneau, N. L., de Koning, A., Sekhon, B., Ntanda, H. N., Kobor, M., Deane, A. J., Morin, A. M., Dewey, D., Campbell, T. S., Giesbrecht, G. F., & APrON Study Team (2020). Parenting Interacts With Plasticity Genes in Predicting Behavioral Outcomes in Preschoolers. The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres, 52(4), 290–307. https://doi.org/10.1177/0844562119863612.
Minard-Colin, V., Aupérin, A., Pillon, M., Burke, G., Barkauskas, D. A., Wheatley, K., Delgado, R. F., Alexander, S., Uyttebroeck, A., Bollard, C. M., Zsiros, J., Csoka, M., Kazanowska, B., Chiang, A. K., Miles, R. R., Wotherspoon, A., Adamson, P. C., Vassal, G., Patte, C., Gross, T. G.Children 's Oncology Group (2020). Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. The New England journal of medicine. 382(23), 2207–2219. https://doi.org/10.1056/NEJMoa1915315.
Santos, T. B dos., Gomes, D. dos S., Sousa, A. B. F de., Rodrigues, Ítalo S. G., Padilha, F. F, & Droppa-Almeida, D. (2021). Prospecção científica e tecnológica de potenciais imunoterapias incluindo vacinas anticâncer com foco em osteossarcoma. Pesquisa, Sociedade e Desenvolvimento. 10 (17), e132101723015. https://doi.org/10.33448/rsd-v10i17.23015.
Schumacher, T. N., & Schreiber, R. D. (2015). Neoantigens in cancer immunotherapy. Science (New York, N.Y.), 348(6230), 69–74. https://doi.org/10.1126/science.aaa4971.
Tan, W. L., Tan, E. H., Lim, D. W., Ng, Q. S., Tan, D. S., Jain, A., & Ang, M. K. (2016). Advances in systemic treatment for nasopharyngeal carcinoma. Chinese clinical oncology. 5(2), 21. https://doi.org/10.21037/cco.2016.03.03.
Taylor, G. S., & Steven, N. M. (2016). Therapeutic vaccination strategies to treat nasopharyngeal carcinoma. Chinese clinical oncology. 5(2), 23. https://doi.org/10.21037/cco.2016.03.20.
Thomas, S., & Prendergast, G. C. (2016). Cancer Vaccines: A Brief Overview. Methods in molecular biology (Clifton, N.J.). 1403, 755–761. https://doi.org/10.1007/978-1-4939-3387-7_43.
Wang, J. J., Liu, Y. H., & Li, G. C. (2015). Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma. International immunopharmacology. 28(2), 1026–1033. https://doi.org/10.1016/j.intimp.2015.07.026.
Yalçın, S., Yalçınkaya, S., & Ercan, F. (2021). Detecção in silico do potencial inibidor de compostos de Passiflora contra a principal protease do SARS-Cov-2 (Covid-19) usando docking molecular e análises dinâmicas. Jornal de Estrutura Molecular, 1240, 130556.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Denilson dos Santos Gomes; Alícia Beatriz Fontes de Souza; Ítalo Samuel Gonçalves Rodrigues; Tatiane Batista dos Santos; Josiene Souza Santos; André Henrique Gomes dos Santos; Daniela Droppa-Almeida
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
